Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOXO1 and PXR effects on imatinib resistance in chronic myeloid leukemia
ChiCTR1800019896Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of imatinib in chronic myelogenous leukemia (CML), sponsored by The Second Xiangya Hospital. Started Dec 2018; status: recruiting.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on ChiCTR1800019896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019896.